Dotmatics

Dotmatics is a developer of research and development software that aims to empower scientists throughout the research process. The company provides an enterprise platform that connects science, data, and decision-making, enhancing efficiency and accelerating innovation. Its software enables scientists and students to analyze data effectively, create 2D graphs, and simplify various tasks related to data analysis, statistics, and graphing. By offering tools tailored to the needs of researchers, Dotmatics facilitates a more streamlined approach to scientific inquiry and development.

Thomas Swalla

CEO and Board Member

15 past transactions

Virscidian

Acquisition in 2024
Virscidian is a technology company that specializes in developing custom analytical software solutions tailored to fit natural laboratory workflows, particularly in biopharmaceutical and agricultural sectors. Their software automates data processing for chromatography and mass spectrometry, streamlining complex laboratory workflows and enhancing productivity through powerful data analysis algorithms and an open architecture.

BioGlyph

Corporate Round in 2024
BioGlyph is a biotechnology software developer focused on accelerating and enhancing the discovery and development of biologics. Its proprietary platform offers user-friendly design tools, agnostic registration, and modern data labeling, facilitating collaboration and innovation in the biologics field.

EasyPanel

Acquisition in 2024
EasyPanel is a technology company that develops software for the pharmaceutical industry. Its core product is a flow cytometry panel design software, which uses a proprietary algorithm to suggest optimized panel configurations based on instrument settings, antigen expression levels, and product availability. Users can edit these suggestions, access product reviews, and receive gating strategy recommendations.

M-Star Simulations

Acquisition in 2024
M-Star Simulations is a software company that focuses on delivering advanced computational fluid dynamics solutions tailored for the chemical, biopharmaceutical, and energy sectors. The company specializes in simplifying the setup and execution of intricate fluid dynamics simulations, enabling clients to optimize their processes within a virtual environment prior to real-world implementation. By providing these simulation services, M-Star Simulations helps organizations improve efficiency and effectiveness in engineering and biological systems.

SoftGenetics

Acquisition in 2023
SoftGenetics develops software analysis tools tailored for genetic researchers and clinicians, addressing the challenges faced in genetic analysis. Its product lineup includes Mutation Surveyor, which identifies DNA variants from Sanger sequencing traces; NextGENe, a tool that refines and extends short sequence reads; GeneMarker, designed for genotyping with user-friendly defaults to streamline setup; and specialized software for forensic profiling and image analysis. Additionally, CGH Explorer assists in detecting genomic regions with copy number alterations. The company's solutions are aimed at enhancing sensitivity and detail in genetic testing, while minimizing false-positive rates, thereby offering researchers and clinicians effective and accessible analysis options.

Omiq

Acquisition in 2021
Omiq is a company specializing in modern cytometry analysis platforms. It integrates machine learning and analytical pipelines with traditional manual analysis methods, providing researchers with a comprehensive software solution for their entire workflow. This platform allows users to transition from raw data to statistical significance using familiar tools enhanced by advanced computational methods and visualizations. The result is deeper insights into biological systems through the tracking of biomarkers within lab samples, facilitating the identification of drug or therapeutic interactions.

Protein Metrics

Acquisition in 2021
Protein Metrics is a Cupertino, California-based company founded in 2011 that specializes in software solutions for analyzing mass spectrometry, chromatography, and capillary electrophoresis data. The company develops advanced tools for protein characterization, designed to keep pace with innovations in scientific instrumentation. Its software employs unique algorithms that assist researchers in minimizing ambiguity, achieving reproducibility, and reducing variability across different laboratories. By providing clear scientific insights, Protein Metrics supports the development of new diagnostics and therapeutics, enhancing research capabilities in the field of biotherapeutics.

LabArchives

Acquisition in 2021
LabArchives is a provider of a web-based software solution designed for the management and documentation of scientific data. Functioning as more than just an Electronic Laboratory Notebook, LabArchives serves as a collaborative platform that enables research scientists to store, organize, share, and publish their findings. The software is available in both cloud-based and locally installed versions, making it accessible to scientists worldwide who seek to enhance their research efficiency. Additionally, LabArchives offers a special Student Edition aimed at high school and undergraduate students at a nominal cost, supporting educational initiatives. The platform helps clients automate data capture, improve collaboration, and manage lab resources, thereby streamlining workflows and bolstering overall laboratory productivity.

De Novo Software

Acquisition in 2021
De Novo Software is a developer of FCS Express, a leading flow cytometry data analysis solution recognized for its rapid growth in the industry. The company focuses on bridging the gap between image cytometry and analytical results, providing custom data analysis tools that enhance the drug development pipeline. By empowering scientists and researchers, De Novo enables users to efficiently extract insights from raw data, significantly reducing the time required for data analysis.

Biobright

Acquisition in 2020
BioBright LLC, incorporated in 2013 and based in Boston, Massachusetts, is a scientific lab data automation company that focuses on advancing data-centric research. The company develops biotechnology solutions that facilitate the automation of data collection from both internal and external sources, enabling real-time tracking of biological experiments. BioBright's platform allows scientists to standardize and analyze critical experimental data while incorporating built-in validation and integrity checks. This commitment to creating a smart laboratory of the future positions BioBright as a key player in enhancing the efficiency and reliability of scientific research. As of June 30, 2020, BioBright operates as a subsidiary of Dotmatics Limited.

nQuery

Acquisition in 2020
nQuery is a search engine for your data.

Dotmatics Canada

Acquisition in 2020
Cytapex Bioinformatics Inc. is a bioinformatics contract research organization based in Burnaby, Canada, specializing in the development of automated data analysis pipelines for cytometry data. Established in 2016, the company offers consulting services that encompass data management, quality control, and data analysis. Cytapex delivers tailored gating and biomarker discovery solutions for complex panels utilized in clinical trials and diagnostics. By focusing on rapid, robust, and reproducible results, Cytapex empowers its clients to efficiently identify low-quality samples and analyze dimly lit data, thereby enhancing the overall quality and reliability of their research outcomes. As of May 2020, Cytapex operates as a subsidiary of Insightful Science, LLC.

SnapGene

Acquisition in 2019
SnapGene is a software development company that provides solutions for researchers in molecular biology, chemistry, and related fields. The company's software is designed to facilitate the planning, visualization, documentation, and sharing of DNA cloning and PCR procedures. By enabling users to create and share files easily, SnapGene helps reduce errors and save time in laboratory workflows. Its tools are aimed at enhancing the efficiency and accuracy of everyday molecular biology tasks, making it a valuable resource for scientists and researchers in various disciplines.

Geneious

Acquisition in 2019
Geneious is an applied bioinformatics company focused on delivering research and development solutions for the biopharmaceutical industry. It offers a comprehensive bioinformatics software platform designed to analyze, interpret, and utilize molecular sequence data. The platform features a suite of molecular biology and next-generation sequencing analysis tools that enhance data management and computational capabilities. By providing these resources, Geneious enables organizations to improve their operational efficiencies and expedite the drug discovery process.

GraphPad Software

Acquisition in 2017
GraphPad Software, Inc. is a company that specializes in developing software tailored for the international scientific community. Founded in 1989 and based in La Jolla, California, GraphPad offers a range of products designed to assist laboratory researchers in data analysis and visualization. Its flagship product, GraphPad Prism, addresses the data handling needs of researchers, while GraphPad InStat provides a step-by-step approach to data analysis. Additionally, GraphPad StatMate aids in determining necessary sample sizes, and GraphPad QuickCalcs is an online tool for various calculations, including radioactivity and statistical tests. The company’s software solutions are created by scientists for scientists, aiming to simplify the complexities of data analysis and enhance the research process.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.